Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.
CONCLUSION: Micafungin is associated with a good safety profile and is an interesting option for preventing invasive fungal infections in the high-risk population of patients presenting with hematological disorders.
PMID: 27126350 [PubMed - as supplied by publisher]
Source: Medecine et Maladies Infectieuses - Category: Infectious Diseases Tags: Med Mal Infect Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Aspergillosis | Aspergillus | Candida | Chemotherapy | Fungal Infections | Hematology | Infectious Diseases | Leukemia | Study | Toxicology